Author

Rahel Riedo

University of BernORCID 0009-0005-7479-4717Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:CRISPR screen· 1

Frequent Co-Authors

Michaela MedováiD· 2 shared Yitzhak ZimmeriD· 2 shared Amiq GazdhariD· 1 shared Aurélie QuintiniD· 1 shared Carlos Pulido-QuetglasiD· 1 shared Daniel M. AebersoldiD· 1 shared Hugo Guillen-RamireziD· 1 shared Joachim AlbersiD· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Michaela MedováORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyMolecular Cancer TherapeuticsPeer-reviewedNov 8, 2024

HPV and p53 status as precision determinants of head and neck cancer response to DNA-PKcs inhibition in combination with irradiation

Liana Hayrapetyan, Selina M. Roth, Aurélie Quintin…·Michaela Medová

12 citationstop 5%

humanexperimental assay

𝕏 PostBluesky

Molecular BiologybioRxivFeb 12, 2020

Enhancing CRISPR deletion via pharmacological delay of DNA-PK

Núria Bosch-Guiteras, Tina Uroda, Hugo Guillen-Ramirez…·Rory Johnson

This paper shows that temporarily inhibiting DNA-PK increases CRISPR-Cas9 deletion efficiency by delaying NHEJ, improving experimental outcomes across multiple cell lines and guide RNAs.

13 citations

humanCRISPR screen

𝕏 PostBluesky